Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma. Zhang S, Zhao Y, He L, Bo C, et al. Clin Res Hepatol Gastroenterol 2022;46:101851.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang S, Zhao Y, He L, Bo C, et al. Effect of camrelizumab plus transarterial chemoembolization on massive hepatocellular carcinoma. Clin Res Hepatol Gastroenterol 2022;46:101851.
PMID: 34923180